Pasithea Therapeutics (KTTA) Current Leases (2022 - 2024)
Pasithea Therapeutics recorded quarterly Current Leases of $32989.0 in Q1 2024, down 59.61% quarter-over-quarter from $81680.0 in Q4 2023, and down 80.0% year-over-year from $164974.0 in Q2 2023.
Pasithea Therapeutics' Current Leases history runs 3 years deep, the most recent figure standing at $32989.0 for Q1 2024.
- In Q1 2024, Current Leases fell 80.0% year-over-year to $32989.0; the TTM figure through Mar 2024 stood at $32989.0 (down 80.0% YoY), while the FY2023 annual figure was $81680.0, down 49.07% from the prior year.
- Current Leases came in at $32989.0 for Q1 2024 at Pasithea Therapeutics, down from $81680.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $258031.0 in Q3 2022 to a low of $32989.0 in Q1 2024.
- A 3-year average of $142950.1 and a median of $162668.0 in 2022 frame the typical range for Current Leases.
- Across the five-year window, Current Leases jumped 67.3% in 2023 and slumped 80.0% in 2024, its largest moves.
- Pasithea Therapeutics' Current Leases stood at $160362.0 in 2022, then plunged by 49.07% to $81680.0 in 2023, then tumbled by 59.61% to $32989.0 in 2024.
- According to Business Quant data, Current Leases over the past three periods registered $32989.0, $81680.0, and $174471.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Pasithea Therapeutics | 17.41 Mn | 17.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 32,989.00 |
| Dec 31, 2023 | 81,680.00 |
| Sep 30, 2023 | 174,471.00 |
| Jun 30, 2023 | 169,676.00 |
| Mar 31, 2023 | 164,974.00 |
| Dec 31, 2022 | 160,362.00 |
| Sep 30, 2022 | 258,031.00 |
| Jun 30, 2022 | 101,418.00 |